Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
NAG
NAGE
NAGE
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
RF Industries
RFIL
100%
0.0pp
Weis Markets
WMK
100%
0.0pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Segments
By segment
See full
Consumer Products segment
11.1%
-27.0%
Other financials
Income statement
See full
Revenue
$31.5M
+3.3%
Gross profit
$20.0M
+3.3%
Operating income
$1.6M
-67.0%
Net income
$6.3M
+24.8%
EPS (diluted)
$0.07
+16.7%
Balance sheet
See full
Cash & equivalents
$66.5M
+19.7%
Total debt
$2.6M
-26.9%
Total equity
$82.3M
+48.8%
Total assets
$114.3M
+40.6%
Cash flow
See full
Operating cash flow
-$1.2M
-115%
Valuation
See full
Market cap
$254.07M
-74.9%
Enterprise value
$190.09M
-79.7%
P/E
13.6×
-43.5×
P/S
2×
-6.8×
Profitability
See full
Gross margin
64.3%
+1.8pp
Operating margin
10%
-2.2pp
Net margin
14.3%
+1.2pp
FCF margin
-70.4%
—
Returns & leverage
See full
Return on equity
27.1%
-6.4pp
Debt / equity
0×
0.0×
Current ratio
4.6×
+0.9×